한글목차

세계 G 단백질 연결 수용체(GPCR) 표적화 시장 규모는 2024년 44억 달러에서 예측 기간 동안 6.8%의 CAGR로 2029년 말에는 61억 달러에 달할 것으로 예상됩니다.

북미 시장은 2024년 18억 달러에서 예측 기간 동안 5.8%의 CAGR로 성장하여 2029년 말에는 23억 달러에 달할 것으로 예상됩니다. 유럽 시장은 2024년 12억 달러에서 예측 기간 동안 7.1%의 CAGR로 성장하여 2029년 말에는 18억 달러에 달할 것으로 예상됩니다.

세계의 G 단백질 연결 수용체(GPCR) 표적화 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법·규제 환경, 신흥 기술 및 기술 개발 동향, 시장 규모 추정과 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약

제2장 시장 개요

• 개요
• GPCR 종류
• GPCR 세포 응답 : 소개
• 질환 생리학에서 GPCR의 중요성
• 규제

제3장 시장 역학

• 개요
• 시장 성장 촉진요인
• 만성질환 발생률 상승
• GPCR 약 수요 증가
• GPCR 연구의 기술적 진보
• 시장 성장 억제요인
• Drug Discovery 과제
• GPCR 구조 연구의 한계
• 시장 기회
• 개별화 암 치료

제4장 신기술과 개발

• 개요
• 신기술
• 새로운 스크리닝 기술
• GPCR 표적 Drug Discovery의 구조 해석
• GPCR 표적 Drug Discovery의 실험 스크리닝
• 특허 분석
• 특허 리뷰 : 출원인별

제5장 시장 세분화 분석

• 시장 개요
• 세분화 내역
• GPCR 표적화 : 각종 기술과 세계 시장
• 시장 분석 : 어세이 유형별
• cAMP 어세이와 cGMP 어세이
• 칼슘 기능 어세이
• 아레스틴 기능 어세이
• 방사성 리간드 결합 및 GTPgammaS 기능 어세이
• 리포터 유전자 어세이
• 기타
• 시장 분석 : 제품 유형별
• 세포주
• 검출 키트
• 세포배양 시약
• 리간드
• 시장 분석 : 용도별
• 종양/암
• 심혈관질환
• 중추신경계 질환
• 호흡기질환
• 기타
• 지역적 내역
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 개요
• 업계 기업 순위
• 업계의 벤처 자금 조달

제7장 GPCR 표적 기술 산업의 지속가능성 : ESG 관점

• 세계의 GPCR 산업의 지속가능성
• ESG 리스크와 등급 : 데이터 이해
• BCC에 의한 견해

제8장 부록

• 정보 출처
• 약어
• 기업 개요
• AGILENT TECHNOLOGIES INC.
• BD
• DANAHER CORP.
• ENZO BIOCHEM INC.
• EPICS THERAPEUTICS
• EUROFINS SCIENTIFIC
• INTERAX BIOTECH AG
• MERCK KGAA
• ORION BIOTECHNOLOGY CANADA LTD.
• PROMEGA CORP.
• QIAGEN
• REVVITY
• TECTONIC THERAPEUTIC
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC

영문목차

The global G protein-coupled receptor (GPCR) market is expected to grow from $4.4 billion in 2024 and is projected to reach $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

The North American GPCR market is expected to grow from $1.8 billion in 2024 and is projected to reach $2.3 billion by the end of 2029, at a CAGR of 5.8% during the forecast period of 2024 to 2029.

The European GPCR market is expected to grow from $1.2 billion in 2024 and is projected to reach $1.8 billion by the end of 2029, at a CAGR of 7.1% during the forecast period of 2024 to 2029.

Report Scope:

This report on the global market for G protein-coupled receptor (GPCR) targeting technologies analyzes the current landscape, including market size and growth trends and segments the market by assay type, product type, application and region. Assay categories include cAMP assays and cGMP assays, calcium functional assays, arrestin functional assays, radioligand binding and GTPgammaS functional assays, reporter gene assays and others. Product types include cell lines, detection kits, cell culture reagents and ligands. Applications include oncology, cardiovascular diseases (CVDs), central nervous system diseases, respiratory diseases and others.

The regions looked at are North America (the U.S., Canada and Mexico), Europe (Germany, the U.K., France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Singapore and Rest of APAC) and the Rest of the World (South America, the Middle East and Africa). The report also includes profiles of leading companies and discusses industry trends, significant products, mergers and acquisitions, and other collaborations or partnerships.

In-text citations are given by the author and the year that the research or study was published. More details on these sources can be found in the table listing them in the Appendix.

Report Includes:

• 22 data tables and 43 additional tables
• An analysis of the global market and technologies for G-protein coupled receptor (GPCR) targeting
• Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the market potential for GPCR targeting technology, industry growth drivers, and forecasts for this market's segments and sub-segments
• Estimates of the market size and revenue forecast for the global GPCR targeting technology market in USD millions, and a corresponding market share analysis by assay type, product type, application and region
• Discussion of the major market dynamics and shifts, and the regulations, industry challenges and macroeconomic factors affecting the demand for GPCR targeting technology over the coming years
• A look at the recent technological breakthroughs in the use of GPCR targeting technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
• Review of the patent filings and research publications for innovations in GPCR targeting technology
• Discussion on the industry's ESG challenges and practices
• Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages
• Insights into the industry structure for GPCR targeting technology, the competitive landscape, clinical trials and ongoing research activity
• Profiles of the major players in the industry, including Promega Corp., Revvity Inc., Thermo Fisher Scientific Inc., Enzo Biochem Inc., and Danaher Corp.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Types of GPCRs
• Introduction of GPCR Cellular Responses
• Importance of GPCRs in Disease Physiology
• Regulatory Aspect

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Rising Incidence of Chronic Diseases
• Growing Demand for GPCR Drugs
• Technological Advances in GPCR Research
• Market Restraints
• Challenges of Drug Discovery
• Limitations of GPCR Structural Studies
• Market Opportunities
• Personalized Cancer Therapy

Chapter 4 Emerging Technologies and Developments

• Overview
• Emerging Technologies
• Novel Screening Technology
• Structural Analysis in GPCR-Targeted Drug Discovery
• Experimental Screening in GPCR-Targeted Drug Discovery
• Patent Analysis
• Patent Review, by Applicant

Chapter 5 Market Segmentation Analysis

• Market Overview
• Segmentation Breakdown
• GPCR-Targeting: Technologies and Global Markets
• Market Analysis by Assay Type
• cAMP Assays and cGMP Assays
• Calcium Functional Assays
• Arrestin Functional Assays
• Radioligand-Binding and GTPgammaS Functional Assays
• Reporter Gene Assays
• Other Assays
• Market Analysis by Product Type
• Cell Lines
• Detection Kits
• Cell Culture Reagents
• Ligands
• Market Analysis by Application
• Oncology/Cancers
• Cardiovascular Diseases
• Central Nervous System Diseases
• Respiratory Diseases
• Other Diseases
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Overview
• Ranking of Companies in the Industry
• Venture Fundings in the Industry

Chapter 7 Sustainability in the GPCR-Targeting Technologies Industry: An ESG Perspective

• Sustainability in the Global GPCR Industry
• ESG Risks and Ratings: Understanding the Data
• BCC Research Viewpoint

Chapter 8 Appendix

• Sources
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BD
• DANAHER CORP.
• ENZO BIOCHEM INC.
• EPICS THERAPEUTICS
• EUROFINS SCIENTIFIC
• INTERAX BIOTECH AG
• MERCK KGAA
• ORION BIOTECHNOLOGY CANADA LTD.
• PROMEGA CORP.
• QIAGEN
• REVVITY
• TECTONIC THERAPEUTIC
• THERMO FISHER SCIENTIFIC INC.
• WUXI APPTEC